In Brief: Pfizer OTC, Moberg, Atrium, C&D, Wockhardt, Herbalife
This article was originally published in The Tan Sheet
Executive Summary
Pfizer expands European OTC business; Moberg expands in U.S. with Bayer brands; Atrium would go private in $1.1 billion deal; C&D not bearish on gummies; GMP warning for two Wockhardt facilities; and Belgian court: Herbalife not a pyramid scheme.
You may also be interested in...
Moberg Sustains Derma Drive, Acquires Prestige Brands' New Skin
The Swedish firm pays $40m for the PediaCare and Fiber Choice brands in addition to New Skin Liquid Bandages, which are available in spray and liquid delivery and are "the main profitability contributor in the acquired portfolio," says CEO Peter Wolpert.
Moberg Sustains Derma Drive, Acquires Prestige Brands' New Skin
The Swedish firm pays $40m for the PediaCare and Fiber Choice brands in addition to New Skin Liquid Bandages, which are available in spray and liquid delivery and are "the main profitability contributor in the acquired portfolio," says CEO Peter Wolpert.
Herbalife Pushes To Counter Pyramid Scheme Narrative
The multilevel marketer of weight-management shakes and other nutritionals says its independent distributor network, far from being a pyramid scheme, in fact is essential in helping people lose weight and adopt healthy lifestyles, according to Herbalife executives.